CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GKOS | Glaukos CORP | Stock-Healthcare | 76.45% | — | -17.51% | |
| 2 | OCUL | Ocular Therapeutix INC | Stock-Other | 11.11% | — | — | |
| 3 | CLVSEUR | Clovis Oncology INC | Stock-Other | 5.66% | — | — | |
| 4 | AKAOQ | Achaogen INC | Stock-Other | 4.92% | — | — | |
| 5 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 1.85% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GKOS | Glaukos CORP | +38.3% | -17.51% | Trim |
| 2 | AKAOQ | Achaogen INC | +2.4% | — | Unchanged |
| 3 | CBAYUSD | Cymabay Therapeutics INC | +0.8% | — | Unchanged |
| 4 | CLVSEUR | Clovis Oncology INC | 0% | — | Unchanged |
| 5 | OCUL | Ocular Therapeutix INC | -4.3% | — | Unchanged |
| 6 | FPRX | Five Prime Therapeutics INC | — | EXIT | Sold out |
| 7 | ✓ | Biotie Therapies Oyj | — | EXIT | Sold out |